一种有前景的针对新冠病毒肺炎细胞因子风暴的靶向治疗方法：人工肝血液净化系统 - Suppr

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.

作者信息

Zhang Yimin, Yu Liang, Tang LingLing, Zhu Mengfei, Jin Yanqi, Wang Zhouhan, Li Lanjuan

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Department of Infectious Diseases, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310022, China.

出版信息

Engineering (Beijing). 2021 Jan;7(1):11-13. doi: 10.1016/j.eng.2020.03.006. Epub 2020 Mar 20.

DOI:10.1016/j.eng.2020.03.006

PMID:32292628

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118608/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09de/7118608/6574bf2c4966/gr1_lrg.jpg

相似文献

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.

Engineering (Beijing). 2021 Jan;7(1):11-13. doi: 10.1016/j.eng.2020.03.006. Epub 2020 Mar 20.

The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19.

Front Immunol. 2020 Dec 23;11:586073. doi: 10.3389/fimmu.2020.586073. eCollection 2020.

Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.

Int Immunopharmacol. 2021 Jan;90:107120. doi: 10.1016/j.intimp.2020.107120. Epub 2020 Oct 31.

Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.

Int J Infect Dis. 2020 Jul;96:618-620. doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.

J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.

Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.

Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.

Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.

Interface Focus. 2021 Dec 10;12(1):20210006. doi: 10.1098/rsfs.2021.0006. eCollection 2022 Feb 6.

Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.

Front Public Health. 2021 Nov 17;9:741125. doi: 10.3389/fpubh.2021.741125. eCollection 2021.

Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.

PLoS One. 2022 Jan 25;17(1):e0262438. doi: 10.1371/journal.pone.0262438. eCollection 2022.

How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α.

Inflamm Res. 2021 Jul;70(7):749-752. doi: 10.1007/s00011-021-01469-8. Epub 2021 Jun 26.

引用本文的文献

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics.

Front Immunol. 2023 Apr 21;14:1064459. doi: 10.3389/fimmu.2023.1064459. eCollection 2023.

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.

Front Pharmacol. 2023 Apr 12;14:1111329. doi: 10.3389/fphar.2023.1111329. eCollection 2023.

Recent trends in Bi-based nanomaterials: challenges, fabrication, enhancement techniques, and environmental applications.

Beilstein J Nanotechnol. 2022 Nov 11;13:1316-1336. doi: 10.3762/bjnano.13.109. eCollection 2022.

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities.

Clin Immunol. 2022 Dec;245:109177. doi: 10.1016/j.clim.2022.109177. Epub 2022 Nov 8.

VIVID: End-to-End Molecular Communication Model for COVID-19.

IEEE Trans Mol Biol Multiscale Commun. 2021 Apr 8;7(3):142-152. doi: 10.1109/TMBMC.2021.3071767. eCollection 2021 Sep.

Molecular Events Involved in Influenza A Virus-Induced Cell Death.

Front Microbiol. 2022 Jan 7;12:797789. doi: 10.3389/fmicb.2021.797789. eCollection 2021.

Neoantigen-reactive T cell: An emerging role in adoptive cellular immunotherapy.

MedComm (2020). 2021 Apr 23;2(2):207-220. doi: 10.1002/mco2.41. eCollection 2021 Jun.

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.

Mol Biomed. 2021;2(1):1. doi: 10.1186/s43556-020-00015-y. Epub 2021 Jan 20.

Hemorrhage and venous thromboembolism in critically ill patients with COVID-19.

SAGE Open Med. 2021 May 31;9:20503121211020167. doi: 10.1177/20503121211020167. eCollection 2021.

The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China.

Aging (Albany NY). 2021 Apr 3;13(7):9243-9252. doi: 10.18632/aging.202838.

本文引用的文献

[Management of COVID-19: the Zhejiang experience].

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.

Clinical Characteristics of Coronavirus Disease 2019 in China.

N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.

Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.

Reducing mortality from 2019-nCoV: host-directed therapies should be an option.

Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

The Middle East Respiratory Syndrome (MERS).

Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001.

Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features.

Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001.

MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile.

Cytokine. 2018 Apr;104:8-13. doi: 10.1016/j.cyto.2018.01.025. Epub 2018 Feb 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献